The Changing Face of Oncology Endpoint Monitoring Date Published: Jul 23, 2021 Article Historically, endpoints in oncology clinical trials centered on tumor response, but this approach alone fails to take into account how well a treatment is tolerated or how patients cope with their symptoms. More recently, industry and regulatory bodies increasingly incorporate patient-reported outcomes to measure soft endpoints. In this article, we explore the value of PROs to clinical trials and outline important considerations for incorporating them into oncology trials. Download Now Share: LinkedInTweet